Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-25-013864
Filing Date
2025-01-28
Accepted
2025-01-28 07:35:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B3 d885645d424b3.htm 424B3 131738
2 GRAPHIC g885645g03l00.jpg GRAPHIC 35691
3 GRAPHIC g885645g20l00.jpg GRAPHIC 42857
  Complete submission text file 0001193125-25-013864.txt   240730
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

EIN.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-284388 | Film No.: 25560949
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)